Lumbar Erector Spinae Plane Block vs Fascia Iliaca Block vs Lumbar Plexus Block for Postoperative Analgesia for Total Hip Arthroplasty
NCT ID: NCT06573931
Last Updated: 2025-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2024-08-29
2025-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lumbar Erector Spinae Plane Block and Fascia Iliaca Compartment Block After Total Hip Arthroplasty
NCT05905510
Comparison Between the Analgesic Efficacy of Erector Spinae Plane Block and Psoas Compartment Block in Hip Surgery
NCT03904095
Thoracolumbar Interfascial Plane Block Versus Bilateral Erector Spinae Plane Block In Lumbar Laminectomy
NCT04757480
Effect of the Quadratus Lumborum Block Versus the Lumbar Plexus for Spiral Thighplasty Surgery
NCT07280182
Fascia Iliaca Versus Quadratus Lumborum Block for Pain Management in Total Hip Replacement.
NCT05504525
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Lumbar erector spinae plane block (LESPB) was reported to lead to effective postoperative analgesia in hip and proximal femoral surgery.
The fascia iliaca block (FIB) is an established and effective technique, especially when US guidance and proximal approaches are used.
lumbar plexus block (LPB) could be safe because of the targeted somatic nerve block in the psoas region which prevents dispensable sympathetic block even in cardiovascular-compromised patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lumbar Erector Spinae Plane Block
Patients will receive lumbar erector spinae plane block at the end of surgery.
Lumbar Erector Spinae Plane Block
Patients will receive lumbar erector spinae plane block at the end of surgery.
Fascia Iliaca Block
Patients will receive fascia iliaca block at the end of surgery.
Fascia Iliaca Block
Patients will receive fascia iliaca block at the end of surgery.
Lumbar Plexus Block
Patients will receive lumbar plexus block at the end of surgery.
Lumbar Plexus Block
Patients will receive lumbar plexus block at the end of surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lumbar Erector Spinae Plane Block
Patients will receive lumbar erector spinae plane block at the end of surgery.
Fascia Iliaca Block
Patients will receive fascia iliaca block at the end of surgery.
Lumbar Plexus Block
Patients will receive lumbar plexus block at the end of surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes.
* American Society of Anesthesiology (ASA) physical status I-III.
* Undergoing total hip arthroplasty under spinal anesthesia.
Exclusion Criteria
* Allergy to any drug used in the study.
* Contraindications to spinal anesthesia (such as Thrombocytopenia (platelets \<100,000/mCL) and coagulopathy (INR \>1.4 or insufficient time since stopping systemic anticoagulation)).
* Epilepsy.
* Psychiatric disease.
* Pre-existing neurologic deficits or neuropathies.
* Pregnancy.
* Pre-existing alcohol/opioid use disorder.
* Previously diagnosed with chronic pain.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Said ElSharkawy
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University
Tanta, El-Gharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36264PR760/7/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.